It’s my favorite interview question…
What’s your secret?
But when it comes to building wealth, I have no secrets.
Unless you consider “looking for good deals” a secret.
Truth is, the only reason I’ve been so successful in creating wealth — particularly in the legal cannabis space — is because I’ve dedicated every waking moment to becoming an expert in the industry… and then finding the best deals.
I’ve read every book on the subject, attended nearly every conference dedicated to the industry, spent hours upon hours networking with the leaders in the space, and, quite frankly, becoming friends with the most powerful players in the market.
That’s actually how I got a piece of one cannabis company before it even went public.
Hefty Gains
Back in May 2016, thanks to a relationship I cultivated with a very powerful financier, I had the opportunity buy shares of a new legal cannabis company called Emblem Corp. (TSX-V: EMC).
Shares were $0.50 apiece, and this was about seven months before the company even went public.
When it did finally go public, it debuted at $2.99. That’s a gain of 498% the second it debuted.
But it gets better.
A month later, the stock crossed $4.00 a share, putting the total gain at 706%.
Not bad at all.
Of course, the best part about this deal was that I was able to share it with members of my Green Chip Stocks community. And those who took advantage are now sitting on some pretty hefty gains.
But those gains are nothing compared to what we’re about to make on our next pre-IPO deal.
Our Next Pre-IPO Deal
One of the biggest gains I ever scored in the legal cannabis space was from a company called OrganiGram Holdings (TSX-V: OGI).
OrganiGram was the first publicly traded cannabis producer providing organically grown cannabis. It was a niche no one was covering, and it was a niche I knew was incredibly lucrative.
I recommended buying shares of OrganiGram when it was trading around $0.40 a share. Today, OrganiGram trades around $2.20. Take a look…
While I maintain that OrganiGram is still one of the top 10 legal cannabis stocks to own, investors now have a new opportunity to invest in another publicly traded cannabis company that’s also providing organic cannabis.
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
And what we made on OrganiGram is peanuts compared to what we’re going to make on our next organic cannabis play: The Green Organic Dutchman.
More Pre-IPO Deals
Back in December 2016 — again, thanks to my connections in the legal cannabis space — I was able to secure pre-IPO shares of The Green Organic Dutchman for just $0.50. Members of my Green Chip Stocks community also had the opportunity to take part.
Now here we are, less than a year later, and the company just announced it’s doing another pre-IPO deal at $1.65 a share.
That’s 230% more than what we paid less than a year ago. And, quite frankly, $1.65 still isn’t even close to where this thing could be by early next year.
That, my friend, is the value of a Green Chip Stocks membership.
And while we’ve made a ton of money already, I have plenty more pre-IPO deals that I’m sharing with Green Chip Stocks members every single month. In fact, I’ll have a new one to share next week. And if you’d like to get access to it, you can.
All you have to do is become a member now.
I would also encourage you to check out my “Beginner’s Guide to Cannabis Investing,” which you can read about here.
As well, you can watch my “Introduction to Cannabis Investing” video here.
Make no mistake…
There’s a ton of money to be made in the legal cannabis space, and we’re taking full advantage. You should, too.
Click here to get started.
To a new way of life and a new generation of wealth…
Jeff Siegel
Jeff is the founder and managing editor of Green Chip Stocks. For more on Jeff, go to his editor’s page.
Want to hear more from Jeff? Sign up to receive emails directly from him ranging from market commentaries to opportunities that he has his eye on.